HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 60 | 60 | 100.0% | |
| HF004 | 2020 | 69 | 74 | 93.2% | |
| HF006 | 2021 | 72 | 78 | 92.3% | |
| HF006 | 2022 | 73 | 75 | 97.3% | |
| HF006 | 2023 | 85 | 89 | 95.5% |
